|Articles|April 1, 2003

Peanut Oil Problems

London -- The use of skin creams containing peanut oil to treat diaper rash, eczema, or other inflammatory skin conditions in babies may lead to peanut allergy in childhood, according to research by Gideon Lack, M.B., B. Ch., and colleagues, based on data from the Avon Longitudinal Study of Parents and Children (ALSPAC).

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!

Related Content

Patrick Burnett, MD, PhD, Outlines Arcutis' Pediatric Strategy for Roflumilast in AD and Psoriasis

ByMarie Bosslett, Assistant Editor,Patrick Burnett, MD, PhD

December 1st 2025

Bridging the Literacy Gap to Strengthen Dermatologic Care

ByKen Korber, PA-C, MHPE, DFAAPA,Kaitlyn Bader, Assistant Managing Editor

November 21st 2025

Roflumilast sNDA Accepted for Plaque Psoriasis in Patients 2 to 5 Years

ByMarie Bosslett, Assistant Editor

November 17th 2025

Advancing Topical Stewardship and Expanding Nonsteroidal Options

ByPeter Lio, MD,Kaitlyn Bader, Assistant Managing Editor

November 14th 2025

Arcutis Completes Enrollment in Phase 2 Study of Roflumilast Cream for Infant AD

ByMarie Bosslett, Assistant Editor

November 13th 2025

Latest CME

Video

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Joseph Gorelick, MSN, FNP-C

Video

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Brad P. Glick, DO, MPH, FAAD

Multimedia

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Register now!

Video

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Video

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Video

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Video

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Video

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Video

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Multimedia

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Peanut Oil Problems

Newsletter

Related Content

Patrick Burnett, MD, PhD, Outlines Arcutis' Pediatric Strategy for Roflumilast in AD and Psoriasis

Bridging the Literacy Gap to Strengthen Dermatologic Care

Roflumilast sNDA Accepted for Plaque Psoriasis in Patients 2 to 5 Years

Advancing Topical Stewardship and Expanding Nonsteroidal Options

Arcutis Completes Enrollment in Phase 2 Study of Roflumilast Cream for Infant AD

Latest CME

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Trending on Dermatology Times

Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results

Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott

Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic

Dermatology Conferences and Meetings Calendar: December 2025

ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN